Studies indicate that the HIF-1 signaling pathway is differentially expressed in the placenta of GDM patients compared to normal controls [55]; HIF-1α expression is closely associated with hyperglycemia, insulin resistance, and inflammation, and it participates in metabolic regulation mediating the development of insulin resistance and diabetes [56]. Here, HIF1A is linked to Hyperglycemia.